ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014